Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that was reported to target ion channel proteins. L-type voltage-dependent Ca2+ channel (LTCC) density and dysfunction is a critical player in heart failure with reduced ejection fraction (HFrEF). However, the underlying cellular mechanisms by which CRBN regulates LTCC subtype Cav1.2α during cardiac dysfunction remain unclear. Here, we explored the role of CRBN in HFrEF by investigating the direct regulatory role of CRBN in Cav1.2α activity and examining how it can serve as a target to address myocardial dysfunction. Cardiac tissues from HFrEF patients exhibited increased levels of CRBN compared with controls. In vivo and ex vivo studies demonstrated that whole-body CRBN knockout (CRBN−/−) and cardiac-specific knockout mice (Crbnfl/fl/Myh6Cre+) exhibited enhanced cardiac contractility with increased LTCC current (ICaL) compared with their respective controls, which was modulated by the direct interaction of CRBN with Cav1.2α. Mechanistically, the Lon domain of CRBN directly interacted with the N-terminal of Cav1.2α. Increasing CRBN levels enhanced the ubiquitination and proteasomal degradation of Cav1.2α and decreased ICaL. In contrast, genetic or pharmacological depletion of CRBN via TD-165, a novel PROTAC-based CRBN degrader, increased surface expression of Cav1.2α and enhanced ICaL. Low CRBN levels protected the heart against cardiomyopathy in vivo. Cereblon selectively degrades Cav1.2α, which in turn facilitates cardiac dysfunction. A targeted approach or an efficient method of reducing CRBN levels could serve as a promising strategy for HFrEF therapeutics. Patients with HFrEF exhibited increased CRBN expression that leads to Cav 1.2 degradation. CRBN directly binds and degrades Cav1.2α through ubiquitination. Cardiomyopathological model of CRBN KO mice improved cardiac contractility with increased Ca2+ transients and Cav1.2α current density.
1 January 2021 in Journal of Lipid and Atherosclerosis
Heart failure (HF) is a multifactorial disease brought about by numerous, and oftentimes complex, etiological mechanisms. Although well studied, HF continues to affect millions of people worldwide and current treatments can only prevent further progression of HF. Mitochondria undoubtedly play an important role in the progression of HF, and numerous studies have highlighted mitochondrial components that contribute to HF. This review presents an overview of the role of mitochondrial biogenesis, mitochondrial oxidative stress, and mitochondrial permeability transition pore in HF, discusses ongoing studies that attempt to address the disease through mitochondrial targeting, and provides an insight on how these studies can affect future research on HF treatment.
The pH level of a wound environment is a crucial biomarker for monitoring wound healing, particularly in chronic wounds, where alkalinity (pH > 7) is linked to bacterial colonization and infection. This study developed and optimized a halochromic sensor film composed of polyvinyl alcohol (PVA), polyethylene glycol (PEG), and bromothymol blue (BTB) to enable rapid and reliable pH-responsive color transitions. Feature selection using Principal Component Analysis (PCA) and the ReliefF algorithm identified Hue, Saturation, and a as key features influencing pH responsivity. Optimization of BTB (0.01–0.05%) and PEG (6–10%) concentrations was conducted using bird-inspired metaheuristic algorithms, including the Parrot Optimizer (PO), Pelican Optimization Algorithm (POA), and Secretary Bird Optimization Algorithm (SBOA). While final fitness values showed negligible variation (188.595647 for GP-PO, 188.595634 for GP-POA, and 188.595634 for GP-SBOA), GP-PO demonstrated superior convergence and stability, efficiently identifying the optimal formulation (0.02% BTB, 6% PEG). The optimized film achieved a complete color transition within 3–5 min, a 23.15% reduction compared to the non-optimized formulation. Statistical analysis revealed that BTB concentration significantly affected response time (p = 0.01), while PEG concentration had no significant effect (p > 0.05). These findings highlight the potential of halochromic films for real-time, non-invasive pH monitoring in chronic wounds.
Microneedle (MN) arrays offer a novel and minimally invasive platform for transdermal drug delivery. This study presents an approach for the design and fabrication of MN array models for biomedical applications using custom 3D-printed micro-molds. Material analysis of the polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) matrix in a 3:1 weight ratio was conducted under varying geometric configurations, curcumin (CUR) dosages, and target penetration depths of 300 to 500 μm. Computational simulation using computer-aided design (CAD) and finite element analysis (FEA) on ANSYS (Canonsburg, PN, USA) measured for total deformation, stress distribution, insertion pressure, and factor of safety. Elimination criteria were applied, narrowing down to specific models that were experimentally validated through material formulation, micro-molding, and material characterization. The selected MN models were analyzed by insertion and penetration efficiency testing on porcine skin. The results showed that higher CUR concentrations reduced mechanical strength and Young’s modulus, while mid-range dosages (2–6 mg) combined with optimized geometric spacing produced MNs with maintained structural integrity and effective performance. Conical microneedles demonstrated the most favorable balance of mechanical stability, controlled swelling behavior, and high insertion efficiency. The study recommends this approach as a feasible and reproducible method for localized wound-healing applications.